Largest biotech by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

CG Oncology has the lowest figure of the 24 biotech ranked by cash on hand, at $32.5M, followed by Adaptive Biotechnologies ($70.5M) and ImmunityBio ($88.3M). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG Oncology$32.5M
Median
$433.1M
Combined market value
$841.8B
Countries
5

Market values as of .

Largest biotech by cash on hand
#CompanyCash on hand ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care$32.5M$7B$78.06 1.12% down 85% up United States
2Adaptive BiotechnologiesADPT · Health Care$70.5M$4.6B$28.39 0.35% down 88% up United States
3ImmunityBioIBRX · Health Care$88.3M$6.5B$6.15 1.76% down 193% up United States
4Halozyme TherapeuticsHALO · Health Care$133.8M$10.9B$95.85 0.13% down 37% up United States
5VaxcytePCVX · Health Care$174M$9.3B$58.75 1.09% down 22% up United States
6Twist BioscienceTWST · Health Care$183M$7.7B$113.34 1.20% up 340% up United States
7Kodiak SciencesKOD · Health Care$209.9M$6.3B$96.40 0.41% down 396% up United States
8Bio-TechneTECH · Health Care$264.7M$11.4B$72.73 0.14% up 26% up United States
9Scholar Rock HoldingSRRK · Health Care$323.5M$5.7B$47.08 4.43% up 14% up United States
10CRISPR TherapeuticsCRSP · Health Care$347.6M$4B$41.38 3.06% up 21% down Switzerland
11Kymera TherapeuticsKYMR · Health Care$357M$10.4B$121.82 0.25% up 87% up United States
12Revolution MedicinesRVMD · Health Care$383.7M$34.3B$158.60 2.52% down 131% up United States
13ExelixisEXEL · Health Care$482.5M$16.7B$68.56 0.09% up 63% up United States
14Krystal BiotechKRYS · Health Care$496.3M$9B$303.09 1.52% up 46% up United States
15RepligenRGEN · Health Care$566M$10.9B$170.29 5.00% up 5% up United States
16Neurocrine BiosciencesNBIX · Health Care$713M$16.7B$164.72 0.72% down 20% up United States
17QiagenQGEN · Health Care$839M$10.3B$49.69 0.13% down 12% up Netherlands
18ImmunovantIMVT · Health Care$902.1M$6.9B$33.34 0.38% up 43% up United States
19ModernaMRNA · Health Care$2.6B$81.9B$202.51 2.08% down 755% up United States
20BiogenBIIB · Health Care$3B$37B$250.55 0.10% down 49% up United States
21argenxARGX · Health Care$3.5B$60.2B$957.70 1.07% up 4% up Belgium
22Gilead SciencesGILD · Health Care$7.6B$209.8B$169.11 0.68% down 33% up United States
23BioNTechBNTX · Health Care$8.5B$21B$84.69 0.20% down 16% down Germany
24AmgenAMGN · Health Care$9.1B$243.1B$449.48 1.85% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which biotech have the lowest cash on hand?

CG Oncology ($32.5M), Adaptive Biotechnologies ($70.5M) and ImmunityBio ($88.3M) have the lowest cash on hand of the 24 biotech ranked here as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

24 are ranked by cash on hand.

What are these biotech worth together?

The 24 biotech ranked by cash on hand have a combined market value of $841.8B as of 18 Nov 2026, 14:51 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.